Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
IGF2BP2 pseudogene 1 (IGF2BP2P1) is classified as a pseudogene—essentially a genomic DNA sequence similar to the coding gene IGF2BP2, but not encoding a functional protein. Pseudogenes arise from gene duplication or retrotransposition events and can be transcribed, but generally lack biological function unless they exert regulatory effects at the RNA level. Literature consistently refers to IGF2BP2 as a functional RNA-binding protein involved in RNA stability and translation control, particularly in cancer, diabetes, and development[2][3]. IGF2BP2P1, however, is not recognized as a canonical target in drug discovery and is not associated with therapeutic intervention, disease processes, or biomarker development in the currently available scientific sources. Its mention is likely due to database annotation or automated gene listing, rather than biological significance.\n\nIf you are researching therapeutic targets, focus on the functional gene **IGF2BP2** rather than the pseudogene **IGF2BP2P1**[2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on IGF2BP2 pseudogene 1 (IGF2BP2P1).